Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Naloxone for shock.

B Boeuf, V Poirier, F Gauvin

    The Cochrane Database of Systematic Reviews
    |October 30, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Can we reduce the risk of neurological injury in critically ill children on initiation of ECLS? A narrative review of potential modifiable factors.

    Perfusion·2025
    Same author

    [Infusion sets in neonatology: What practices in France?]

    Annales pharmaceutiques francaises·2021
    Same author

    [Antimicrobial prophylaxis for caesarean delivery: changes in practice and administration before incision, feasibility study to paediatricians in Auvergne].

    Annales francaises d'anesthesie et de reanimation·2012
    Same author

    [Favourable outcome after fetoscopic laser surgery for twin-twin transfusion syndrome: experience of an emerging centre].

    Gynecologie, obstetrique & fertilite·2011
    Same author

    [A lethal variant of Netherton syndrome in a large inbred family].

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2011
    Same author

    Pulmonary injury after intravenous hydrocarbon injection.

    Paediatrics & child health·2010
    Same journal

    Interventions to prevent or cease electronic cigarette use in children and adolescents.

    The Cochrane database of systematic reviews·2026
    Same journal

    Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

    The Cochrane database of systematic reviews·2026
    Same journal

    Interventions for smoking cessation in inpatient psychiatry settings.

    The Cochrane database of systematic reviews·2026
    Same journal

    Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

    The Cochrane database of systematic reviews·2026
    Same journal

    Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

    The Cochrane database of systematic reviews·2026
    Same journal

    Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

    The Cochrane database of systematic reviews·2026
    See all related articles

    Naloxone (an opiate antagonist) improved blood pressure in human shock patients. However, further randomized controlled trials are needed to confirm its clinical usefulness in treating shock.

    Area of Science:

    • Pharmacology
    • Critical Care Medicine
    • Clinical Trials

    Background:

    • Pre-clinical evidence suggests opioid peptides are involved in shock.
    • Case reports on naloxone's efficacy in human shock are conflicting.
    • A meta-analysis was conducted to resolve this controversy.

    Purpose of the Study:

    • To evaluate the effectiveness and safety of naloxone in human shock.
    • To assess the methodological quality of relevant clinical trials.

    Main Methods:

    • A meta-analysis of randomized controlled trials (RCTs) was performed.
    • Bibliographic searches were conducted up to December 2002.
    • Data on study design, intervention, outcomes, and quality were extracted by three independent reviewers.

    Related Experiment Videos

    Main Results:

    • Six RCTs involving 126 patients with various shock types were included.
    • Naloxone therapy significantly improved hemodynamic parameters, including mean arterial pressure (+9.33 mmHg).
    • While the death rate was lower in the naloxone group, this finding was not statistically significant and showed heterogeneity.

    Conclusions:

    • Naloxone demonstrates a significant positive effect on blood pressure in human shock.
    • The overall clinical utility of naloxone for shock treatment requires further investigation.
    • Additional high-quality RCTs are necessary to definitively establish naloxone's role in shock management.